Sigachi Industries Ltd
Sigachi Industries Ltd is a pharmaceutical company that generates revenue primarily through the development, manufacturing, and sale of pharmaceutical products.
Business. Sigachi Industries Ltd (SIGC.NS) is a pharmaceutical company engaged in the development and sale of healthcare products. The firm is headquartered in India and is primarily listed on the National Stock Exchange of India. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Sigachi Industries Ltd (SIGC.NS) is a pharmaceutical company engaged in the development and sale of healthcare products. The firm is headquartered in India and is primarily listed on the National Stock Exchange of India. Specific details regarding its operating segments and geographic revenue mix are not available.
Sigachi Industries Ltd maintains a relatively conservative capital structure, with a debt-to-equity ratio of 0.35, indicating a moderate reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 1.67, suggesting it can cover its short-term obligations but with limited buffer. However, the company's net cash position is negative after subtracting total debt, which raises concerns about its ability to meet long-term obligations without additional financing.
In terms of profitability, the company's return on equity (ROE) is 3.5%, and its return on assets (ROA) is 2.17%. These figures are below the typical thresholds for strong performance in the pharmaceutical industry, indicating that the company is not generating returns that are significantly above its cost of capital. The operating margin, calculated as operating income divided by revenue, is 12.33%, which is in line with the industry median of 12.5%.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases the company's exposure to regional economic and regulatory risks. The company's revenue concentration in a single segment also limits its ability to offset performance shortfalls in one area with gains in another.
Looking ahead, the company's revenue is projected to grow by 4.5% in the current fiscal year and by 3.2% in the next fiscal year, based on the outlook provided in the financial data. This growth is modest and suggests a stable but not aggressive expansion strategy. The company's capital expenditures are negative, indicating that it is not investing in new assets and may be reducing its operational footprint or repaying debt.
The risk assessment for Sigachi Industries Ltd highlights a medium liquidity risk and a low dilution risk. The company's liquidity risk is primarily due to its negative net cash position after accounting for total debt, which could necessitate additional financing in the near term. The dilution risk is low, as the number of shares outstanding has not changed between the basic and diluted counts, indicating no imminent threat from share issuance. The company has not disclosed any recent events such as major filings or transcripts that would suggest significant changes in its business strategy or financial position.
The company's recent financial filings and disclosures do not indicate any major strategic shifts or operational disruptions. The absence of recent events suggests a stable but potentially stagnant business environment for Sigachi Industries Ltd.
- Sigachi Industries Ltd has a moderate debt-to-equity ratio of 0.35, indicating a balanced capital structure.
- The company's ROE of 3.5% and ROA of 2.17% are below the industry median, suggesting suboptimal returns on invested capital.
- Revenue is concentrated in a single business segment, increasing exposure to sector-specific risks.
- The company's projected revenue growth is modest, with a 4.5% increase expected in the current fiscal year.
- The company faces medium liquidity risk due to a negative net cash position after subtracting total debt.
- The dilution risk is low, as the number of shares outstanding has not changed between basic and diluted counts.
Bull / Bear case
Generated · model-assistedRevenue grew at a 26.2% CAGR over four years, demonstrating strong top-line expansion momentum.
Net income expanded at a 23.1% CAGR, indicating consistent profitability growth alongside revenue increases.
Free cash flow surged 296.9% year-over-year, highlighting a significant improvement in cash generation capabilities.
High credit risk flags suggest potential vulnerabilities in the company's ability to meet financial obligations.
Debt-to-equity ratio of 0.35 is below the cohort median, suggesting higher leverage relative to peers.
Cash conversion ratio of 0.86 trails the 0.95 cohort median, indicating weaker cash flow quality.
Medium liquidity risk flags indicate potential challenges in meeting short-term financial obligations promptly.
In focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Sigachi Industries Ltd Market data — financials · 2026-05-29